Drug Cuts Involuntary Movements in Huntington’s Patients By 25 Percent
The medication tetrabenazine cut down involuntary movement in patients with Huntington’s disease on average by about 25 percent, with many patients experiencing a greater improvement, according to a study in the February 14 issue of the journal Neurology.
Feb 14, 2006